How many stocks are there of Sartorius?
The current number of stocks of Sartorius is 68.42 M undefined.
Sartorius Stocks 2024
Sartorius Stocks
68.42 M
Ticker
SRT.DE
ISIN
DE0007165607
WKN
716560
In 2024, Sartorius had 68.42 M outstanding stocks, a 0% change from the 68.42 M stocks in the previous year.
The Sartorius Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2029e | 68.42 |
| 2028e | 68.42 |
| 2027e | 68.42 |
| 2026e | 68.42 |
| 2025e | 68.42 |
| 2024e | 68.42 |
| 2023 | 68.42 |
| 2022 | 68.42 |
| 2021 | 68.42 |
| 2020 | 68.39 |
| 2019 | 68.39 |
| 2018 | 68.39 |
| 2017 | 68.39 |
| 2016 | 68.39 |
| 2015 | 68.39 |
| 2014 | 68.19 |
| 2013 | 68.2 |
| 2012 | 68.2 |
| 2011 | 68.2 |
| 2010 | 68.2 |
| 2009 | 68.2 |
| 2008 | 68.2 |
| 2007 | 68.2 |
| 2006 | 68.2 |
| 2005 | 68.2 |
| 2004 | 68.2 |
Sartorius shares outstanding DE0007165607 · 716560
The number of shares was Sartorius in 2023 — This indicates how many shares 68.416 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Sartorius earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Sartorius's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Sartorius’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sartorius's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 68.2 M Aktien |
| 2005 | 68.2 M Aktien |
| 2006 | 68.2 M Aktien |
| 2007 | 68.2 M Aktien |
| 2008 | 68.2 M Aktien |
| 2009 | 68.2 M Aktien |
| 2010 | 68.2 M Aktien |
| 2011 | 68.2 M Aktien |
| 2012 | 68.2 M Aktien |
| 2013 | 68.2 M Aktien |
| 2014 | 68.19 M Aktien |
| 2015 | 68.39 M Aktien |
| 2016 | 68.39 M Aktien |
| 2017 | 68.39 M Aktien |
| 2018 | 68.39 M Aktien |
| 2019 | 68.39 M Aktien |
| 2020 | 68.39 M Aktien |
| 2021 | 68.42 M Aktien |
| 2022 | 68.42 M Aktien |
| 2023 | 68.42 M Aktien |
| 2024e | 68.42 M Aktien |
| 2025e | 68.42 M Aktien |
| 2026e | 68.42 M Aktien |
| 2027e | 68.42 M Aktien |
| 2028e | 68.42 M Aktien |
| 2029e | 68.42 M Aktien |
Sartorius Aktienanalyse
What does Sartorius do?
Sartorius AG is a globally operating company specializing in the development and manufacturing of laboratory equipment and process technologies. It was founded in 1870 by industrialist and entrepreneur Florenz Sartorius in Göttingen, Germany. The company initially focused on the sale of scales, weights, and measuring instruments but has since expanded and diversified its product line. Today, Sartorius AG is a world leader in the bioprocessing and laboratory equipment sectors and is known for its innovative products and procedures. The company's business model revolves around the development of high-tech products for applications in biotechnology, pharmaceuticals, and the food industry. It operates in two main business segments: Bioprocess Solutions and Lab Products & Services. The Bioprocess Solutions segment provides solutions and services for biopharmaceutical production, including filtration, fermentation, fluid management, and cell cultures. The products in this segment are typically disposable consumables used in the production of biopharmaceutical agents. The Lab Products & Services segment offers a wide range of laboratory equipment, from scales and microbiology equipment to ultrafiltration devices. These instruments are used by researchers and scientists in academic, industrial, and pharmaceutical laboratories worldwide. Furthermore, an important part of Sartorius' portfolio includes bioreactors and fermenters. These specialized devices are used for cultivating cells and microorganisms and are particularly important in biotechnology and vaccine production. Sartorius has established itself as a leader in this field through its innovative and high-performance products. In addition to the pharmaceutical, biotechnology, and laboratory sectors, Sartorius is also active in environmental technology. The company provides products and services for water analysis and purification, which are in demand in industries such as pharmaceuticals, food production, and environmental analysis due to their precise and reliable results. Sartorius demonstrates its innovation through the use of technologies such as machine learning and artificial intelligence. For example, the company offers the "Ambr" solution for fast and reliable modeling of production scenarios for biopharmaceutical agents. Machine learning techniques are employed to generate more data and make better decisions. Overall, Sartorius AG is a global company with a wide range of products and services for the biotechnology, pharmaceutical, chemical, and food industries. The company's innovation is evident in its continuous advancement of procedures, technologies, and products. With a strong market position and clear strategic direction, Sartorius will continue to be an important player in the industry and support the work of researchers and scientists worldwide with its high-performance products. Sartorius ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Sartorius's Shares Outstanding
Sartorius's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Sartorius’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Sartorius’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Sartorius’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Sartorius stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Sartorius are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Sartorius evolved in recent years?
The number of shares of Sartorius has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Sartorius as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Sartorius?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Sartorius pay?
Over the past 12 months, Sartorius paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sartorius is expected to pay a dividend of 1.85 EUR.
What is the dividend yield of Sartorius?
The current dividend yield of Sartorius is .
When does Sartorius pay dividends?
Sartorius pays a quarterly dividend. This is distributed in the months of April, April, April, May.
How secure is the dividend of Sartorius?
Sartorius paid dividends every year for the past 26 years.
What is the dividend of Sartorius?
For the upcoming 12 months, dividends amounting to 1.85 EUR are expected. This corresponds to a dividend yield of 0.92 %.
In which sector is Sartorius located?
Sartorius is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sartorius kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sartorius from 4/4/2024 amounting to 0.73 EUR, you needed to have the stock in your portfolio before the ex-date on 4/2/2024.
When did Sartorius pay the last dividend?
The last dividend was paid out on 4/4/2024.
What was the dividend of Sartorius in the year 2023?
In the year 2023, Sartorius distributed 1.25 EUR as dividends.
In which currency does Sartorius pay out the dividend?
The dividends of Sartorius are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Sartorius stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Sartorius
Our stock analysis for Sartorius Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sartorius Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
